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http://dxAbstract: Fibromyalgia syndrome (FMS) is characterized by widespread chronic pain, fatigue, sleep
disorders, and cognitive-emotional disturbance. Patients with FMS exhibit increased sensitivity to
experimental pain and pain-related cues, as well as deficits in emotional regulation. The present
study investigated the spatiotemporal patterns of brain activations for observed pain in 19 patients
with FMS and 18 age-matched, healthy control individuals using event-related potential analysis.
Patients with FMS attributed greater pain and unpleasantness to pain pictures, relative to healthy
control participants. An augmented late positive potential (LPP) component (>500 milliseconds)
was found in patients viewing both pain and nonpain pictures, and this amplitude difference in
the LPP covaried with perceived unpleasantness of pictures. Mid-latency potentials (250–450 millisec-
onds) demonstrated similar amplitude increases of positive potentials in the FMS patient group. By
contrast, the short-latency positive potential (140 milliseconds) was reduced in patients with FMS
relative to healthy control participants. Results suggest amplitude increases to mid- to long-latency
cortical activations in patients with FMS, which are known to reflect emotional control and motiva-
tional salience of stimuli.
Perspective: Patients with FMS demonstrate increased activations associated with pain and non-
pain pictures. The findings suggest that even innocuous, everyday visual stimuli with somatic conno-
tations may challenge the emotional state of patients with FMS. Our study points toward the
importance of cognitive-emotional therapeutic approaches for the treatment of FMS.
ª 2015 Published by Elsevier Inc. on behalf of the American Pain Society
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widespread chronic pain and tenderness, psycholog-
ical disturbance, cognitive dysfunction and sleep dis-
orders.6,65 Patients with FMS demonstrate reduced pain
thresholds39,46,54 and augmented brain responses15,29,57
during experimental pain. Patients also exhibit
hypervigilance to pain17 and deficits in affective process-
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.doi.org/10.1016/j.jpain.2015.04.008proposed that such dysfunctional emotional processing
could play an important role in the development and
maintenance of pain in FMS.4,17,26,58
Observing pain in others requires complex affective
processing to empathizewith the physical and emotional
experiences of another, and pain-related stimuli elicit
greater evaluation than nonpainful scenes because
they aremore novel and important for survival.22 Despite
the aforementioned psychological features of FMS, pro-
cessing of observed pain remains poorly understood,
although a recent study reported augmented hypervigi-
lance for observed pain in patients with FMS, but normal
levels of empathic concern.63 The central sensitization
theory of FMS suggests that sensory thresholds are
decreased as a consequence of central alterations,
potentially resulting from neuroplasticity changes,
which lead to augmented processing of peripheral stim-
uli.59 Underlying central alterations may affect the pro-
cessing of observed pain in FMS, or alternatively,717
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research has demonstrated that central sensitization
may play a role in amplifying nonpainful somatosensory
stimuli in patients with FMS,21 whereas observed pain
was shown to facilitate the detection of tactile stimuli
in patients with FMS in a similar manner to healthy peo-
ple.63 The temporal resolution of event-related potential
(ERP) analysis allows for insight into the precise timing of
processing alterations for observed pain in patients with
FMS. This could shed light on the complex relationship
between central processing and observed pain in FMS.
ERP studies have investigated the temporal dynamics
of neural responses to observed pain in healthy people,
revealingmodulationofbothearly (110–180milliseconds
after stimulus), and late (300–700milliseconds after stim-
ulus) ERP components.22,33,35,44 Patientswith FMS exhibit
heightened autonomic and subjective responses to
negative affective stimuli4 and alterations to early ERP
components27 when viewing painful facial expressions,
but it is not known whether any such changes are
evident during observation of pain stimulation in others.
Existing ERP research for perceived pain points tomod-
ulation of cortical processing by top-down influences
such as self-perspective35,44 or relevant previous
experience.19 Such factors are also likely to play a role
in differentiating patients with FMS from healthy popu-
lations. Previously, clinical populations with deficits in
empathic processing such as autistic spectrum disorder
and juvenile psychopathic patients were shown to
exhibit reduced ERP components during observed pain
relative to healthy people.13,23 Conversely, because
patients with FMS are generally hypervigilant to pain
cues,17 wewould expect them to report greater observed
pain for visual pain stimuli and to display corresponding
modulation of cortical activations.
To investigate neural processing of pain-related visual
stimuli in patients with FMS, ERPs associated with
viewing of pain and nonpain pictures were analyzed.
We hypothesized that patients with FMS, relative to
healthy people, would attribute greater pain to pain
scenes and manifest greater amplitudes in ERP compo-
nents known to be associated with emotional control,
such as the late positive potential (LPP).31,53Methods
Participants
Nineteen female patients (age 40.01 6 7.95 years,
mean 6 standard deviation [SD]) diagnosed with FMS
took part in the study. Patients were recruited from
outpatient fibromyalgia clinics at 2 regional National
Health Service Foundation Trust hospitals: the Walton
Centre, Liverpool, United Kingdom, and Wirral Univer-
sity Teaching Hospital, Wirral, United Kingdom. All pa-
tients fulfilled American College of Rheumatology
criteria for diagnosis with fibromyalgia,65 and those
with additional disease or disorders that are not
commonly comorbid with FMS were excluded. Patients
were aged between 19 and 52 years, and mean duration
of symptoms was 9.62 6 6.97 years. Patients using medi-cationswith central nervous system effectswhowere not
deemed suitable for withdrawal were excluded. Analge-
sics (such as co-codamol) were withdrawn for at least
3 days before recordings; withdrawal was managed by
the clinical team during consultations. Mild analgesic
medications such as paracetamol were permitted. At
their request, 6 patients on low-dose antidepressant
medication (eg, 10 mg citalopram or nortriptyline per
day) were permitted to take part after undergoing with-
drawal for 5 days before recordings. Six patients were
using no medications for management of their FMS,
and the remaining 7 patients either were using permis-
sible doses of commonmedications with minimal central
nervous efficacy or withdrew from nonpermitted
medications, such as co-codamol, for at least 3 days
before recordings. Themedication profiles in the patient
group are shown in Table 1 and reflect the difficulty
in recruiting a homogenous cohort of patients with
FMS to evaluate neural activity associated with observed
pain in the absence of centrally acting medications.
Eighteen female controls (age 39.23 6 7.99 years,
mean6 SD)were recruited through Internet and campus
advertisements. Volunteers were age matched to pa-
tients with FMS, and those taking regular medication
or currently diagnosed with any disease or disorder
were excluded. All patients and volunteers were
compensated for time and travel expenses. Written
informed consent was obtained from all participants in
accordance with the Declaration of Helsinki. The study
was approved by the National Research Ethics Commit-
tee of theUnited Kingdomand the Research Governance
Committees of both National Health Service Foundation
Trust hospitals.Procedure
Participants were accompanied to the Sensory-Motor
Laboratory in the Walton Centre National Health Service
Foundation Trust to undergo electrode preparation.
During the experiment participants were seated in a
comfortable chair positioned 1 m from a 48.2-cm
(19-in) computer monitor. The experiment consisted of
a single recording encompassing viewing of 100 trials
and lasting 20 minutes. Each trial (Fig 1) began with a
3-second resting interval, when subjects viewed a black
fixation cross on a gray background, then a color photo-
graph was presented for 3 seconds followed by a resting
interval of 2 seconds and a 4-second response period.
During the response period, a 7-point rating scale with
anchors ‘‘no pain’’ to ‘‘worst possible pain’’ was pre-
sented. Participants were required to repeatedly click a
mouse button to incrementally advance the scale to
attribute the amount of pain they perceived to be
evident in the scene.
The images used were similar to those used in previous
studies.1,22,30,33,37,38,40 Fifty pictures displayed hands or
feet in situations containing pain, such as a knife
cutting bread in a manner that would endanger the
hand, or a foot standing on a shard of glass (Fig 1). A
further 50 pictures depicted nonpain scenes, which
were graphically matched to the aforementioned pain
Table 1. Demographic, Clinical, and Medication Profile Data of Patients With FMS
PATIENT CODE AGE (Y) DURATION OF SYMPTOMS (Y) FIQ BDI PCS MEDICATION PROFILE
FM01 40 12.00 64.70 16.00 16.00 b-Blockers
FM02 42 5.00 59.02 20.00 21.00 Diclofenac
FM03 39 3.00 71.99 21.00 20.00 Gabapentin
FM04 22 6.00 68.32 22.00 10.00 No medication
FM05 43 4.50 77.75 31.00 14.00 Tramadol, sertraline
FM06 44 15.00 61.92 8.00 1.00 Co-codamol
FM07 33 7.00 55.55 17.00 16.00 Co-codamol
FM08 43 4.00 72.15 21.00 12.00 Gabapentin, nortriptyline
FM09 41 18.00 19.11 5.00 14.00 Citalopram
FM10 48 6.00 39.22 14.00 3.00 Citalopram, tramadol
FM11 37 3.50 56.40 6.00 .00 Pregabalin, nortriptyline, co-codamol
FM12 49 3.00 25.36 5.00 2.00 No medication
FM13 52 10.00 48.96 14.00 19.00 Co-codamol
FM14 46 2.00 75.37 20.00 25.00 Co-codamol
FM15 45 18.00 48.42 6.00 5.00 No medication
FM16 30 4.00 82.56 41.00 28.00 No medication
FM17 26 6.00 74.74 20.00 5.00 No medication
FM18 32 16.00 69.67 33.00 33.00 Gabapentin, duloxetine, Co-codamol
FM19 37 4.50 80.23 37.00 31.00 No medication
Fallon et al The Journal of Pain 719scenes but contained no pain, such as a knife safely cut-
ting bread. Pictures were presented in a pseudorandom-
ized order, and the same picture type was not presented
more than 3 times in succession. After the experiment,
participants rated each picture in terms of affective
valence (ranging from neutral to extremely unpleasant)
and arousal (neutral to extremely arousing) using 9-
point Self-Assessment Manikin scales.10 Each participant
also completed a series of questionnaires incorporating
the Beck Depression Inventory (BDI),5 Pain Catastrophiz-
ing Scale (PCS),60 and the Fibromyalgia Impact Question-
naire (FIQ).11Recordings
Electroencephalographic (EEG) datawere recorded us-
ing a 64-channel Biosemi Ag-ACl active 2-electrode
system (Biosemi BV, Amsterdam, The Netherlands). Elec-Figure 1. The flowchart of the experiment illustrates one trial
beginningwith a rest interval (3 seconds) followed by visual pre-
sentation of a pain or nonpain picture (3 seconds), followed by a
second rest interval (2 seconds) and a response period (4 sec-
onds). During the response period, patients used repeated
mouse clicks to incrementally advance a scale and attribute
the amount of pain they considered to be evident in the image.trode positions were allocated according to the
extended 10–20 system with respect to 3 anatomical
landmarks: the 2 preauricular points and the nasion.
Two bipolar, flat Ag-ACl external reference electrodes
were attached to the mastoid processes, and electro-
oculograms were recorded using bipolar electrodes posi-
tioned above and below the right eye. The recording
bandpass filter was .16–100 Hz, and the sampling rate
was 512 Hz.
EEG Data Analysis
EEG data were preprocessed using BESA v.6.0 (MEGIS
Software GmbH, Gr€afelfing, Germany). Data were
initially spatially transformed into reference-free data
using common average reference method,41 and oculo-
graphic and electrocardiographic artifactswere removed
using principal component analysis.7 Data were visually
inspected for the presence of movement or muscle arti-
facts, and epochs contaminated with artifacts were
manually excluded. The experimenter (N.F.) was blinded
to trial type when excluding artifacts from raw EEG data.
The mean number of trials remaining after artifact
correction was 42.6 6 5.3 (mean 6 SD) and 42.6 6 5.0
for pain pictures, and 43.5 6 4.5 and 42.3 6 6.1 for non-
pain pictures in patient and healthy control groups,
respectively. There was no difference between FMS and
healthy groups in the mean number of trials allowed
for either picture condition (P > .05).
ERPs associated with the onset of pain and nonpain
pictures were averaged for the interval ranging from
200 milliseconds to 1,200 milliseconds relative to stim-
ulus onset (717 time points). A 1,200-millisecond epoch
was selected for ERP analysis because this period was
found to adequately cover peaks in global field power
and butterfly plots corresponding to the early-, mid-,
and long-latency ERP components. The baseline period
was from 200 milliseconds to 0 milliseconds relative to
the onset of the picture, and EEG data were bandpass-
720 The Journal of Pain Altered Processing of Observed Pain in Fibromyalgiafiltered from .5 to 40 Hz and downsampled to 256 Hz.
Finally, data were exported to Matlab v.8.10 (The Math-
works Inc, Natick, MA) for statistical analysis using the
EEGLAB toolbox.20
Grand-averaged global field power, scalp isopotential
maps, and butterfly plots were used to define the center
of time windows, ranging from 20 to 150 milliseconds
and encompassing the peak activity for each component,
to be exported for statistical analysis. For each compo-
nent, a 2-way analysis of variance (ANOVA) for repeated
measures (Group  Picture type) was performed across
all electrodes to identify clusters of electrodes showing
significant main effects or interactions. A 95% confi-
dence level was used, and permutation analysis tech-
nique47 with 2,000 permutations was used to correct
for the performance of multiple tests over 64 electrodes.
In each component, clusters of electrodes demonstrating
significant ANOVA effects were concatenated, and the
mean amplitude for the time window was exported for
further statistical analysis using 2-way ANOVA in SPSS
version 21 (IBM Corp, Armonk, NY). All values from
ANOVA analyses were adjusted with Greenhouse-
Geisser ε correction to account for violation of the
assumption of sphericity.
Subjective ratings of pain, unpleasantness, and arousal
for each type of image were analyzed using a 2-way
(Group  Picture type) mixed ANOVA in SPSS. Post hoc
t-tests were used to investigate significant interac-
tion effects, and a 95% confidence level was used
throughout. Participants whose picture ratings fell
outside 3 SDs of the groupmeanwere excluded from sta-
tistical analyses of the specific rating to prevent extreme
values from adversely influencing results. To evaluate
whether the previous medication profile of patients
influenced picture ratings for pain, valence, and arousal,
we analyzed ratings within the patient cohort using a
2-way mixed ANOVA (no medication; Withdrawn from
common medications  Picture type) in SPSS.
To analyze whether clinical symptoms were related to
the differences seen in ERP components of patients with
FMS, Spearman correlation analysis was performed in
the FMS patient group, with ERP amplitudes from elec-
trodes demonstrating significant group effects and BDI,
FIQ, and PCS scores. To further investigate whether sub-
jective ratings for each picture type were related to the
alterations in cortical processing, a 2-way mixed analysis
of covariance (ANCOVA) was performed using the
BMDP2V program (Statistical Solutions Ltd, Cork,
Ireland) with subjective ratings of pain, unpleasantness
and arousal implemented as covariates, and BDI, PCS,
and FIQ scores were used as covariates in SPSS.Mediation
analysis3 was used to investigate whether the relation-
ship between the amplitude of the ERP components
and fibromyalgia group status or picture type would be
moderated by subjective ratings of pictures as pointed
to by ANCOVA analysis. We first determined the magni-
tude of the predictive power and significance for each
relationship using linear regression analysis in SPSS. For
results demonstrating significant mediation, a Sobel
test was performed to confirm the effect of subjective
ratings.Results
Self-Report Ratings
Table 2 shows pain, affective valence, and arousal rat-
ings (mean 6 SDs) attributed to pain and nonpain pic-
tures for patients with FMS and healthy control groups.
A 2-waymixed ANOVA revealed a significant main effect
of picture type on the amount of pain participants attrib-
uted to scenes, with greater pain attributed to pain
pictures (F(1,35) = 176.2, P < .001). A significant group
effect was evident (F(1,35) = 4.6, P = .039), and the
Group  Picture type interaction effect was also signifi-
cant (F(1,35) = 4.5, P = .041). Post hoc between-patients
t-test analysis revealed that patients with FMS attributed
significantly greater pain scores to pain pictures than did
healthy control individuals (t(35) = 2.26, P = .03), but
there was no difference between ratings of nonpain pic-
tures (t(35) = .92, P = .36).
One healthy control individual was excluded from
analysis of valence and arousal ratings because the rat-
ings fell outside 3 SDs of the group mean. Subjective rat-
ings of affective valence for each image showed a main
effect of picture type (F(1,34) = 84.66, P < .001), with
pain pictures scoring higher for unpleasantness. A main
effect of group (F(1,34) = 4.52, P = .041) and a significant
Group  Picture type interaction effect (F(1,34) = 5.96,
P = .021) were also evident. Post hoc analysis revealed
significantly greater unpleasantness ratings for pain pic-
tures in the FMS patient group relative to the healthy
control group (t(34) = 2.3, P = .028), but no difference
was found between valence ratings for nonpain pictures
(t(34) = .45, P = .66). For subjective ratings of arousal, a
main effect of picture type was observed
(F(1,34) = 74.70, P < .001), with pain pictures eliciting a
stronger arousal response than nonpain pictures. How-
ever, no group effect was evident (F(1,34) = 2.51,
P = .12). The Group  Picture type interaction effect ap-
proached, but did not achieve, significance
(F(1,34) = 3.9, P = .056). ANOVA comparison of picture
ratings for withdrawn (compared with nonmedicated)
patients revealed no significant effects of medication
on picture ratings for observed pain (F(1,17) = .44,
P = .52), valence (F(1,17) = .22, P = .64), or arousal
(F(1,17) = .40, P = .53). The expected effect of picture
typewas significant for all 3measures, but no interaction
effects were observed.ERP Analysis
Figs 2A and 2B illustrate the butterfly plot and grand
average global field power of ERPs, which were used to
identify peak time points for the center of time epochs
covering each component shown in Table 3. In both
groups and conditions, ERPs consistently displayed a
negative potential component from 110 milliseconds to
170 milliseconds over frontal-central regions (N1) and a
corresponding positivity located over the occipital lobe
(P1; hereafter the time period of these concomitant po-
tentials is referred to as P1/N1). Subsequently, a positive
potential was evident from 190 to 240 milliseconds
over the vertex (P2), and a negative deflection from
Figure 2. (A) The butterfly plot showing grand average ampli-
tudes for each electrode in all subjects and both picture types;
arrows indicate peak times used for the center of time windows
of interest. (B) Grand-averaged global field power for all sub-
jects and both picture types. (C)Mean topographic isopotential
maps for time epochs encompassing components of interest for
FMS patient and healthy control groups and for each picture
type.
Table 2. Mean Scores (6 SD) for Pain, Affective
Valence, and Arousal Attributed to Pain and
Nonpain Pictures in Patients With FMS and
Healthy Control Groups
PATIENTS WITH FMS HEALTHY Controls
PAIN NONPAIN PAIN NONPAIN
Pain 4.9 6 1.2 1.5 6 .5 4.1 6 1.2 1.4 6 .3
Valence 4.4 6 2.0 1.3 6 .4 3.0 6 1.6 1.2 6 .3
Arousal 4.1 6 2.0 1.3 6 .6 3.2 6 1.6 1.4 6 .8
Fallon et al The Journal of Pain 721260 to 330 milliseconds (N2) over the frontal-central re-
gion. This was followed by a positive potential compo-
nent from 370 to 450 milliseconds (P3) and an LPP from
500 to 800 milliseconds, both located over the posterior
parietal region. The spatiotemporal pattern of compo-
nents reflects those seen in previous studies using ERP
analysis of pain and nonpain pictures.22,33,44,51 Scalp
topographies for each component for pain and
nonpain pictures and FMS and healthy control groups
are shown at peak time intervals in Fig 2C.
Table 3 shows mean amplitudes (6 SD) and results of a
2-way mixed ANOVA for each significant cluster of
electrodes in each ERP component. In the time epoch en-
compassing the P1/N1 component (135–155 millisec-
onds), a cluster of electrodes located over the right
occipital region of the scalp demonstrated a significant
group effect, with the healthy control group exhibiting
a greater positivity relative to the FMS patient group.
No significant effect of picture type or group was seen
during the P2 component (210–230 milliseconds). How-
ever, the N2 (280–310milliseconds) component exhibited
a group difference, with patients with FMS demon-
strating an exaggerated positivity over occipital elec-
trodes relative to the healthy control group.
During the time period of the P3 potential (370–
410 milliseconds), a stronger positive deflection was
evident over right parietal electrodes in patients with
FMS, relative to healthy individuals. A similar effect was
seen over central-parietal electrodes during the LPP
(500–650 milliseconds). Furthermore, during the LPP
component, a picture effect was also seen in the same
central-parietal electrodes, with pain pictures eliciting
an augmented positive deflection relative to nonpain
pictures. Fig 3 shows the scalp isopotential maps of ERP
components for each group and picture type at peak
time points, as well as average ERP curves from signifi-
cant electrodes and bar charts illustrating mean ampli-
tudes for each group and condition.Correlation, Covariate, and Mediation
Analysis
Spearman correlation analysis indicated that the am-
plitudes of electrode clusters demonstrating group dif-
ferences in each component of interest were not
correlated with BDI, FIQ, or PCS scores in the FMS patient
group for either picture type. However, a 2-way mixed
ANCOVA with valence, arousal, and subjective pain rat-ings implemented as covariates indicated that valence
ratings significantly covaried with the group difference
seen in the central-parietal cluster of electrodes in the
time interval encompassing the LPP (F(1,31) = 4.52,
P = .042). Similarly, valence ratings also demonstrated a
significant covariation with the picture effect seen in
the same component (F(1,31) = 14.46, P < .001). Neither
pain nor arousal ratings demonstrated significant
Table 3. Clusters of Electrodes Showing Significant ERP Component Effects in 2-Way Mixed ANOVA
TIME (MS)
FMS HEALTHY
ELECTRODES ANOVA F PPAIN NONPAIN PAIN NONPAIN
P1/N1 135–155 .29 6 .78 .33 6 .75 .65 6 .72 .91 6 .96 CP6, P4, P6 Group 4.66 .038
N2 280–310 4.32 6 3.18 4.73 6 2.94 2.71 6 1.91 2.73 6 1.89 POz, Oz, O1, O2 Group 4.80 .035
P3 370–420 1.35 6 1.08 1.19 6 1.46 .42 6 1.56 .31 6 1.35 CPz, CP2, CP4 Group 4.34 .045
LPP 500–650 2.92 6 1.04 2.06 6 1.00 1.96 6 1.31 1.42 6 1.30 Cz, CPz, C2, CP2 Picture 37.56 .000
LPP 500–650 — — — — — Group 5.06 .031
ERP amplitudes (mean 6 SD) for pain and nonpain pictures are shown with F statistics and P values.
722 The Journal of Pain Altered Processing of Observed Pain in Fibromyalgiacovariation with the effects seen in any of the compo-
nents. Similarly, clinical measures in the form of BDI,
FIQ, and PCS scores did not significantly covary withFigure 3. (A) Three-dimensional mean isopotential maps for each g
component that demonstrated significant ANOVA effects. White circ
ferences in amplitude. (B)Mean ERP curves from select electrodes fo
epoch showing a significant ANOVA effect of ERP amplitudes. (C) Bar
electrodes in each group and condition. Red denotes patients with fi
nonpain, green is healthy control individuals with pain pictures, andgroup or picture type effects in any of the components
analyzed. Supplementary Fig 1 illustrates the results of
mediation analyses between FMS group status or pictureroup and condition are shown at the peak time points for each
les indicate location of electrodes demonstrating significant dif-
r each group and condition. Gray shaded areas signify the time
chart illustratingmean amplitudes and standard errors for select
bromyalgia viewing pain pictures, blue represents fibromyalgia
black denotes healthy control individuals for nonpain pictures.
Fallon et al The Journal of Pain 723type and LPP brain potential activations with valence rat-
ings as mediating variables. Analyses indicate that
valence ratings did not mediate the FMS group differ-
ence in central-parietal cortical activity during the time
period of the LPP component, because the relationship
between ratings and the brain potential was not signifi-
cant. However, valence ratings did demonstrate a signif-
icantmediation of the relationship between picture type
and amplitudes of the central-parietal LPP, confirmed by
a Sobel test; z = 2.19, P = .029. Including valence ratings in
the model led to significant reduction in the proportion
of variance accounted for by picture type (see
Supplementary Fig 1B).Discussion
Patients with FMS attributed greater pain and un-
pleasantness to pain pictures than did healthy control
individuals, which corroborates previous findings in pa-
tients with FMS using negative affective pictures.4 Rela-
tive to healthy control participants, patients with FMS
exhibited an augmented LPP over central-parietal elec-
trodes, and pain pictures also elicited stronger ERPs in
this LPP component for both groups. These amplitude
differences covaried with subjective reports of unpleas-
antness of pictures. Further, patients with FMS demon-
strated a similar pattern of augmented positive
potentials in mid-latency components (N2 and P3), con-
trasting with reduced amplitudes in the short-latency
(P1) visual component located over the occipital lobe.
The LPP was previously associated with late cognitive
evaluation of painful stimuli12,23,50; for example, LPP
activation was augmented during a pain judgment task
but diminished during a distraction counting task.22 In
the present study, LPP responses for pain, relative to non-
pain pictures, were enhanced for both groups in accor-
dance with previous findings,22,36 but the response for
both types of picture was also significantly stronger in
patients with FMS relative to healthy control
participants. Clinical populations with deficits in
empathic processing were previously shown to exhibit
reduced LPP amplitudes relative to healthy people,13
whereas the augmented LPP in patients with FMS ap-
pears to reflect heightened sensitivity to painful, and
even nonpainful, somatic pictures.
The LPP was previously proposed as a marker for
affective regulation,31,53 and both the group and
picture differences seen in LPP responses covaried with
subjective valence ratings, which supports this
hypothesis. Alterations to affective processing and
emotional regulation are well documented in
FMS,4,61,62,66 and augmented LPP components were
recently proposed as a mechanism for internal
regulation of affective responses to perceived pain
stimuli in highly empathic people.36 Thus, the LPP
appears particularly relevant for affective processing
during observation of pain. Previously, cognitive-
behavioral therapy in phobic participants was shown to
improve emotional regulation and prolong exposure
times to phobic picture stimuli and also to cause concom-
itant increases in the LPP.42,43 LPP amplitude increases inpatients with FMS may indicate upregulation of coping
mechanisms for environmental pain cues, and
appropriate psychological therapies to desensitize
patients with FMS to environmental pain cues could
have implications for reducing primary pain
symptoms.17,26 Furthermore, because the analysis
revealed no correlations or covariation effects with
other relevant factors such as BDI or PCS scores, it is
unlikely that the differences seen in these components
are related to concomitant affective disorders such as
depression. Although ANCOVA analyses point to some
relevance for emotional processing and this activation
difference, mediation analyses revealed that valence
ratings do not solely govern the degree of activation in
this region during the LPP. However, mediation
analyses did demonstrate a significant role for valence
ratings in the differences seen in LPP activations
between picture types. This finding indicates that
perceived valence is at least partially responsible for
the increased LPP component activations associated
with pain pictures in both patients with FMS and
healthy people.
The P3 component located over the right posterior pa-
rietal region was similarly augmented in patients with
FMS relative to healthy control participants. Previously,
the P3 component was linked with top-down processing
relating to task relevance or motivational significance of
stimuli,49,53 which would suggest an increased allocation
of top-down resources for both pain and nonpain
pictures in patients with FMS. Thus, enhanced P3 activa-
tions could indicate a heightened significance for so-
matic cues in FMS, resulting in an augmented response
to both types of pictures. Patients with generalized anx-
iety disorders exhibited a similar trend, with functional
MRI (fMRI) studies revealing heightened amygdala acti-
vations associated with anticipation of aversive and
even neutral visual stimuli.34,52 Experienced physicians
viewing pain pictures demonstrate reduced P3
amplitudes and subjective pain ratings for observed
pain caused by desensitization of the salient aspects of
such stimuli.19 In effect, patients with fibromyalgia
demonstrate the opposite phenomenon, in that they
manifest augmented P3 responses, which suggests
increased salience and attention for pain and nonpain
somatic visual stimuli in patients with FMS.
The augmented P3 and LPP responses occurred over
parietal electrodes. In the past the parietal cortex was
functionally labeled as integrative or association cor-
tex,16 with perhaps a particular relevance for
visuospatial or motor processing.18,25 However, more
recently the functional role of posterior parietal
cortex in top-down processing for visual attention or
salience has been highlighted (reviewed by Bisley
and Goldberg8). In particular, the lateral intraparietal
area acts as a multifaceted integrative interface, bind-
ing visuospatial, motor, and cognitive information into
an organized topography to specify attentional prior-
ity according to demand.28 Evidence suggests that P3
and LPP components are important for top-down pro-
cessing of emotional or aversive visual stimuli,31,32,53
and the underlying cortex is similarly recognized for
724 The Journal of Pain Altered Processing of Observed Pain in Fibromyalgiaits integrative role in perception, action, and
cognition,8,28 which suggests that this cortical region
could be particularly relevant for FMS mechanisms.
Patients with FMS showed reduced amplitudes of the
P1 positive potential seen over right occipital electrodes
relative to healthy control participants. Increased P1 am-
plitudes were previously seen in healthy people during
observation of pain pictures relative to nonpain pic-
tures,22,56 which also accords with the activation
profiles of fMRI studies.1,40 By contrast, patients later
demonstrated increased amplitudes for the positive
potential located over the occipital region of the scalp
during the period of the N2 component, which reflects
the profile seen in P3 and LPP amplitude differences. A
similar pattern of early impairment of visual processing
followed by later augmentation of activations for
perceived pain was recently demonstrated in an fMRI
study of visual checkerboard stimuli with patients with
FMS.45 Therefore, early sensory processing appears
to be affected in patients with FMS, although
the spatiotemporal pattern of brain activations indicates
predominantly augmented mid- to long-latency
responses to both pain and nonpain stimuli.
The participants attributed their pain ratings 2 seconds
after picture offset. Although this procedure is similar to
previous ERP analyses of observed pain stimuli,22 it is
important to consider that any interlude requires the
involvement of working memory to ascribe appropriate
pain ratings to each picture. Previously, P3 and LPP com-
ponents were shown to be involved in working memory
processing,2,55 and affective or arousing stimuli are
better remembered than less arousing pictures.9,64
Furthermore, as in previous studies,23 ratings for affec-
tive valence and arousal of pictures were included after
the period of recording to limit the duration of the
experiment. Because these appraisals were made afterthe initial EEG presentations, familiarity or priming ef-
fects could influence the ratings attributed to images.
Participants were not matched for menstrual cycle phase
or menopausal status, which can influence pain in
FMS,14,48 and this should be considered for future
research; similarly, a further limitation concerns the
influence of social factors such as level of education,24
because such data were not collected in the present
study. The findings also point to the possibility that pa-
tients with FMS could also exhibit differences in process-
ing of nonpainful negative affective images, and this
prospect warrants further study.
Augmented mid-latency (P3) and long-latency (LPP)
positive potential components over the parietal region
of the scalp signified the strongest differences seen in
FMS, which leads us to the conclusion that the period
of late cognitive evaluation of pain cues is particularly
affected in FMS. The augmented ERP responses were
evident in patients with FMS across both pain and non-
pain pictures, which is indicative of generalized hyper-
vigilance to somatosensory stimuli. The significant
covariance with affective valence ratings during the
LPP, as well as previous research highlighting the impor-
tance of this component for affective regulation, em-
phasizes the relevance of this time period for
alterations to processing of observed pain in patients
with FMS. In the future, this late component may lend
itself to the investigation of therapeutic interventions
aimed at improving psychological and affective aspects
of FMS.Supplementary data
Supplementary data related to this article can be
found at http://dx.doi.org/10.1016/j.jpain.2015.04.008.References
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